Data can help inform patient treatment and ultimately improve care--or at least that's the dream. In reality, many connected health solutions drown users in a deluge of data that their healthcare providers may or may not be able to trust. Abbott's FreeStyle Libre Pro System for continuous glucose monitoring, which recently won FDA approval, gets it right with a more strategic approach. A healthcare professional outfits patients with a small sensor, worn on the back of the arm, that measures glucose levels every 15 minutes for up to 14 days. After those two weeks, the patent returns to the doctor's office, where their physician scans the sensor to download the data for review and discussion.
[Image courtesy of ABBOTT LABORATORIES]
|Hear Abbot Diabetes Care's global head of market access and economics discuss reimbursement trends impacting connected health at the BIOMEDevice San Jose conference on December 7.|